These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
159 related items for PubMed ID: 10854207
21. Val158Met Polymorphism in catechol-O-methyltransferase gene associated with risk factors for breast cancer. Hong CC, Thompson HJ, Jiang C, Hammond GL, Tritchler D, Yaffe M, Boyd NF. Cancer Epidemiol Biomarkers Prev; 2003 Sep; 12(9):838-47. PubMed ID: 14504192 [Abstract] [Full Text] [Related]
22. Catechol-O-methyltransferase Val 108/158 Met polymorphism in premenopausal breast cancer patients. Sazci A, Ergul E, Utkan NZ, Canturk NZ, Kaya G. Toxicology; 2004 Nov 15; 204(2-3):197-202. PubMed ID: 15388245 [Abstract] [Full Text] [Related]
23. Catechol-O-methyltransferase and breast cancer risk. Millikan RC, Pittman GS, Tse CK, Duell E, Newman B, Savitz D, Moorman PG, Boissy RJ, Bell DA. Carcinogenesis; 1998 Nov 15; 19(11):1943-7. PubMed ID: 9855007 [Abstract] [Full Text] [Related]
24. Catechol-O-methyltransferase-mediated metabolism of 4-hydroxyestradiol inhibits the growth of human renal cancer cells through the apoptotic pathway. Chang I, Liu J, Majid S, Saini S, Zaman MS, Yamamura S, Shahryari V, Chiyomaru T, Deng G, Dahiya R, Tanaka Y. Carcinogenesis; 2012 Feb 15; 33(2):420-6. PubMed ID: 22159223 [Abstract] [Full Text] [Related]
25. Variations in catechol O-methyltransferase activity in rodent tissues: possible role in estrogen carcinogenicity. Li SA, Purdy RH, Li JJ. Carcinogenesis; 1989 Jan 15; 10(1):63-7. PubMed ID: 2910532 [Abstract] [Full Text] [Related]
26. Catechol-O-Methyltransferase (COMT)-mediated methylation metabolism of endogenous bioactive catechols and modulation by endobiotics and xenobiotics: importance in pathophysiology and pathogenesis. Zhu BT. Curr Drug Metab; 2002 Jun 15; 3(3):321-49. PubMed ID: 12083324 [Abstract] [Full Text] [Related]
27. Polymorphic catechol-O-methyltransferase gene, duration of estrogen exposure, and breast cancer risk: a nested case-control study in Taiwan. Lin WY, Chou YC, Wu MH, Jeng YL, Huang HB, You SL, Chu TY, Chen CJ, Sun CA. Cancer Detect Prev; 2005 Jun 15; 29(5):427-32. PubMed ID: 16191465 [Abstract] [Full Text] [Related]
28. Genetic polymorphisms in catechol-O-methyltransferase, menopausal status, and breast cancer risk. Thompson PA, Shields PG, Freudenheim JL, Stone A, Vena JE, Marshall JR, Graham S, Laughlin R, Nemoto T, Kadlubar FF, Ambrosone CB. Cancer Res; 1998 May 15; 58(10):2107-10. PubMed ID: 9605753 [Abstract] [Full Text] [Related]
29. Progesterone regulates catechol-O-methyl transferase gene expression in breast cancer cells: distinct effect of progesterone receptor isoforms. Salama SA, Jamaluddin M, Kumar R, Hassan MH, Al-Hendy A. J Steroid Biochem Mol Biol; 2007 May 15; 107(3-5):253-61. PubMed ID: 17689241 [Abstract] [Full Text] [Related]
30. Defining the role of echinocandin catechol functional groups in the development of secondary hepatocellular carcinoma. Julius JM, Gaikwad A, Lowry A, Lewis RE, Lozano RD, Dalrymple JL, Coleman RL, Smith JA. J Antimicrob Chemother; 2012 Feb 15; 67(2):422-9. PubMed ID: 22129592 [Abstract] [Full Text] [Related]
32. The role of catechol-O-methyltransferase in catechol-enhanced erythroid differentiation of K562 cells. Suriguga, Li XF, Li Y, Yu CH, Li YR, Yi ZC. Toxicol Appl Pharmacol; 2013 Dec 15; 273(3):635-43. PubMed ID: 24141029 [Abstract] [Full Text] [Related]
33. Catechol-O-Methyltransferase (COMT) gene polymorphism and breast cancer risk in young women. Bergman-Jungeström M, Wingren S. Br J Cancer; 2001 Sep 14; 85(6):859-62. PubMed ID: 11556837 [Abstract] [Full Text] [Related]
34. Estrogen down regulates COMT transcription via promoter DNA methylation in human breast cancer cells. Wu Q, Odwin-Dacosta S, Cao S, Yager JD, Tang WY. Toxicol Appl Pharmacol; 2019 Mar 15; 367():12-22. PubMed ID: 30684530 [Abstract] [Full Text] [Related]
35. Catechol-O-methyltransferase Val 108/158 Met polymorphism and breast cancer risk: a case control study in Syria. Lajin B, Hamzeh AR, Ghabreau L, Mohamed A, Al Moustafa AE, Alachkar A. Breast Cancer; 2013 Jan 15; 20(1):62-6. PubMed ID: 22124994 [Abstract] [Full Text] [Related]
36. The impact of Catechol-O-methyl transferase knockdown on the cell proliferation of hormone-responsive cancers. Tolba MF, Omar HA, Hersi F, Nunes ACF, Noreddin AM. Mol Cell Endocrinol; 2019 May 15; 488():79-88. PubMed ID: 30904591 [Abstract] [Full Text] [Related]
37. Genetic susceptibility of catechol-O-methyltransferase polymorphism in Japanese patients with breast cancer. Inoue H, Shibuta K, Matsuyama A, Yoshinaga K, Sadanaga N, Ueo H, Barnard GF, Mori M. Oncol Rep; 2005 Sep 15; 14(3):707-12. PubMed ID: 16077979 [Abstract] [Full Text] [Related]
38. Biochemistry and pharmacology of catechol-O-methyltransferase inhibitors. Nissinen E, Männistö PT. Int Rev Neurobiol; 2010 Sep 15; 95():73-118. PubMed ID: 21095460 [Abstract] [Full Text] [Related]
39. Expression and intracellular localization of catechol O-methyltransferase in transfected mammalian cells. Ulmanen I, Peränen J, Tenhunen J, Tilgmann C, Karhunen T, Panula P, Bernasconi L, Aubry JP, Lundström K. Eur J Biochem; 1997 Jan 15; 243(1-2):452-9. PubMed ID: 9030772 [Abstract] [Full Text] [Related]
40. Estrogens metabolism associated with polymorphisms: influence of COMT G482a genotype on age at onset of canine mammary tumors. Dias Pereira P, Lopes CC, Matos AJ, Pinto D, Gärtner F, Lopes C, Medeiros R. Vet Pathol; 2008 Mar 15; 45(2):124-30. PubMed ID: 18424824 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]